(Q46846758)

English

Multiple endocrine neoplasia 2A due to a unique C609S RET mutation presents with pheochromocytoma and reduced penetrance of medullary thyroid carcinoma

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/16343103

Multiple endocrine neoplasia 2A due to a unique C609S RET mutation presents with pheochromocytoma and reduced penetrance of medullary thyroid carcinoma (English)

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/16343103

phaeochromocytoma

1 reference

based on heuristic

inferred from title

multiple endocrine neoplasia

1 reference

based on heuristic

inferred from title

author name string

William B Kinlaw

1

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/16343103

Sarah M Scott

2

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/16343103

Robert A Maue

3

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/16343103

Vincent A Memoli

4

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/16343103

Robert D Harris

5

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/16343103

Gilbert H Daniels

6

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/16343103

Donna M Porter

7

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/16343103

Dorothy R Belloni

8

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/16343103

Edward T Spooner

9

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/16343103

Manfred M Ernesti

10

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/16343103

Walter W Noll

11

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/16343103

publication date

1 December 2005

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/16343103

Clinical Endocrinology

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/16343103

63

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/16343103

6

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/16343103

676-682

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/16343103

Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2005.02400.X

21 January 2018

Seminars in medicine of the Beth Israel Hospital, Boston. The RET proto-oncogene in multiple endocrine neoplasia type 2 and Hirschsprung's disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2005.02400.X

21 January 2018

Can sporadic medullary thyroid carcinoma be biochemically predicted? Prospective analysis of 66 operated patients with elevated serum calcitonin levels

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2005.02400.X

21 January 2018

Germ-line mutations in nonsyndromic pheochromocytoma

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2005.02400.X

21 January 2018

Mechanism of activation of the ret proto-oncogene by multiple endocrine neoplasia 2A mutations

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2005.02400.X

21 January 2018

Guidelines for diagnosis and therapy of MEN type 1 and type 2.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2005.02400.X

21 January 2018

Multiple endocrine neoplasia type 2: evaluation of the genotype-phenotype relationship.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2005.02400.X

21 January 2018

RET germline mutation in codon 791 in a family representing 3 generations from age 5 to age 70 years: should thyroidectomy be performed?

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2005.02400.X

21 January 2018

Phenotypic expression of a family with multiple endocrine neoplasia type 2A due to a RET mutation at codon 618.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2005.02400.X

21 January 2018

Amplification and overexpression of mutant RET in multiple endocrine neoplasia type 2-associated medullary thyroid carcinoma.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2005.02400.X

21 January 2018

Identifiers

10.1111/J.1365-2265.2005.02400.X

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/16343103

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/16343103

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46846758&oldid=2134537669"